Testing the testers

Number 51

1 November 2012 0

Treating the right patient with the right therapy at the right time depends on having the right picture of every patient’s key biological markers. A number of initiatives are now springing up across Europe to [more]

Newsround

Number 51

1 November 2012 0

Selected reports edited by Janet Fricker Glioblastoma: temozolomide offers alternative to radio-therapy in elderly patients => The Lancet Both temozolomide and hypofractionated radiotherapy should be considered as standard treatment options for elderly patients with glioblastoma, [more]

My World

Number 51

1 November 2012 0

Maria João Cardoso is head breast surgeon at the Champalimaud Cancer Centre in Lisbon. She founded the patient support centre Mama Help, and leads a research group at the Institute for Systems and Computer Engineering, [more]

Personalised medicine: a note of caution

1 September 2012 0

Tailoring a patient’s treatment to the particular biology of their cancer holds out the enticing prospect of avoiding over-treatment and reducing unnecessary toxicity. But delivering the right option for the right patient at the right [more]

1 2 3 5
UA-77507851-1